Hosted on MSN28d
United Therapeutics Stock Down Despite Q4 Earnings & Sales BeatUnited Therapeutics markets four products for pulmonary arterial hypertension (PAH ... model estimate of $424.8 million. Remodulin (including Remunity Pump) sales rose 17% year over year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback